Key findings 

The clinical evidence surrounding the use of the Juxta range is fairly limited – and for the Juxtalite product is lacking.

The long-term effectiveness of the technology versus traditional bandages is also unclear. However, there are data to show that Juxta products may lead to reduction in wound size as a proxy for healing, a reduction in nurse resource required to reapply compression, and therefore there is potential for resource savings to be gained from use of the devices.

Further studies should investigate their medium and longer-term effectiveness

What were we asked to look at?

We were asked to provide a high level overview of the Juxta range of products, which are inelastic reusable wraparound garments, used to apply measurable compression to limbs. Juxtacures provides below the knee compression and is used in the management of venous leg ulcers (VLUs) when oedema is present.

Juxtalite also provides below the knee compression, and is suitable where there is no oedema and for the prevention of recurrence.

Juxtafit products are used for lymphoedema, and come in a variety of styles to provide arm or leg compression as required.

Why is this important?

Multi-layered compression bandaging is the current recommended treatment for VLUs, but patients are reliant on a healthcare professional for their application, adjustment and removal.

The use of the Juxta range is an alternative to the traditional bandaging used for VLUs and lymphoedema; patients have the potential to promote self-care in the community and reduce nursing time and resources without the need to markedly change current care pathways.

Referred by 

medi UK, the manufacturer of the technology